Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial.
Cortes J, Apperley J, Lomaia E, Moiraghi B, Undurraga Sutton M, Pavlovsky C, Chuah C, Sacha T, Lipton JH, Schiffer CA, McCloskey J, Hochhaus A, Rousselot P, Rosti G, de Lavallade H, Turkina A, Rojas C, Arthur CK, Maness L, Talpaz M, Mauro M, Hall T, Lu V, Srivastava S, Deininger M.
Cortes J, et al. Among authors: schiffer ca.
Blood. 2021 Nov 25;138(21):2042-2050. doi: 10.1182/blood.2021012082.
Blood. 2021.
PMID: 34407543
Free PMC article.
Clinical Trial.